The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Expert review

Efficacy of Cilostazol in reducing restenosis in patients undergoing contemporary stent based PCI: a meta-analysis of randomised controlled trials

EuroIntervention 2009;5:384-393.

1. University of Michigan Cardiovascular Medicine, VA Ann Arbor Health Care System, Ann Arbor, MI, USA; 2. Second Hospital of Tianjin Medical University, Cardiovascular Center, Tianjin, China; 3. Cardiovascular Center, Korea University Guro Hospital, Seou

Aims: Cilostazol has been associated with reduction in restenosis in patients undergoing coronary and peripheral arterial angioplasty. Our objective was to evaluate the impact of cilostazol

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article

The pericardium covered stent (PCS)